All SARS-CoV-2 articles
-
NewsVaccinated patients hospitalized with COVID-linked acute kidney injury less likely to need dialysis after discharge
Vaccinated patients hospitalized with COVID-19 who developed acute kidney injury had better outcomes than unvaccinated patients with the same condition, new research suggests. The study found vaccinated patients were less likely to stay on dialysis after discharge, and more likely to survive, than unvaccinated patients.
-
NewsGeographic bias in virus naming: Lessons from coronavirus show it’s better to act early
A new study highlights the need to avoid geographically-based naming right from the outset of a pandemic. It analyzes the impact of the WHO’s introduction of the Covid nomenclature based on Greek letters - Alpha, Beta, Delta, etc.
-
NewsStudy indicates that severe forms of COVID-19 infection in children may increase cardiovascular disease risks
Scientists analysed blood samples from 147 children across different COVID-19 conditions and identified significant metabolic disruptions beyond the acute viral infection phase. These alterations affect how the body processes fats (triglycerides and cholesterol) critical to healthy heart structure.
-
NewsA promising therapeutic agent for treating excessive inflammation due to COVID-19
Researchers show that iguratimod, a rheumatoid arthritis drug, reduces COVID-19-induced inflammation in mice without suppressing antiviral immunity.
-
NewsSARS-CoV-2 protein found to spread between cells, triggering immune attack on healthy cells
A new study reveals that the SARS-CoV-2 nucleocapsid protein can spread from infected to uninfected cells, triggering an immune response that mistakenly targets healthy cells.
-
NewsPeople with COVID-like symptoms took up to nine months post-infection to regain mental well-being
New research finds that people with COVID-like symptoms returned to optimal physical well-being an average of three months after infection, but took up to nine months to return to top mental well-being.
-
NewsUltra-selective aptamers give viruses a taste of their own medicine
Inspired by the way viruses attach to cells, scientists have developed a method for engineering ultra-selective aptamers. The synthetic molecules bind to targets like viral spike proteins, making them useful for biomedical diagnostics and treatments.
-
NewsCritical step in COVID viral infection identified
Researchers have uncovered a mechanism that SARS-CoV-2, the virus that causes COVID-19, uses to protect itself inside the body as it works to replicate and infect more cells. Without this protective mechanism, viral infection is dramatically reduced.
-
NewsNew AI reimagines infectious disease forecasting
A new AI tool to predict the spread of infectious disease outperforms existing state-of-the-art forecasting methods. The tool could revolutionize how public health officials predict, track and manage outbreaks of infectious diseases including flu and COVID-19.
-
NewsNew platform can diagnose infectious disease immune protection using one drop of fingertip blood
Researchers have developed a compact diagnostic platform that can evaluate antibody protection against COVID-19 using only a single microliter of fingertip blood. It delivers a comprehensive immune profile in just 40 minutes.
-
NewsGlobal Virus Network issues scientific guidance on new COVID-19 variant NB.1.8.1 and vaccine protection
The Global Virus Network (GVN) is closely monitoring the emergence of a newly identified SARS-CoV-2 variant, NB.1.8.1, a sublineage of the Omicron family first identified in January 2025 and which has rapidly spread across Asia and into other regions.
-
NewsGlobal study: COVID-19 and adenoviral vaccines tied to GBS risk, not mRNA vaccines
A large-scale study in a population covering more than 230 million people sheds light on the relationship between Guillain-Barré syndrome after COVID-19 vaccines or SARS-CoV-2 infection.
-
NewsComputer-identified antiviral drug candidates confirmed by lab experiments
An interdisciplinary research team has identified two antiviral drug candidates effective against a wide range of viruses. The study demonstrates how combining computer-aided modeling with laboratory validation can speed up the development of new antiviral drugs.
-
NewsResearchers develop paper-based diagnostic tool for rapid, affordable infectious disease detection
A team of scientists has developed a breakthrough paper-based diagnostic device that can detect COVID-19 and other infectious diseases in under 10 minutes, without the need for sophisticated lab equipment or trained personnel.
-
NewsNew mRNA vaccine is more effective and less costly to develop, Pitt study finds
A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study.
-
NewsNew diagnostic tool uses bioluminescence to detect viruses
Researchers are shining a powerful new light into the viral darkness with the development of Luminescence CAscade-based Sensor (LUCAS), a rapid, portable, highly-sensitive diagnostic tool for processing complex biological samples.
-
NewsYeast produces human DNase1 for the first time
The protein DNase1 is used to treat cystic fibrosis but it takes considerable effort and cost to produce it in immortalized hamster cells. Researchers have now produced it in yeast cells for the first time.
-
NewsMicrobial proteins reveal chemical signatures of body sites and inflammation
A new study shows that protein sequences associated with microbial communities in the human gut have uniquely low stoichiometric water content and undergo counterintuitive chemical shifts toward chemically reduced states during inflammation.
-
NewsDisrupting the residual triggers of COVID-19 in patients with long COVID
Spatial transcriptomics reveals activation of SARS-CoV-2-related signaling pathways in the epipharynx of patients with long COVID.
-
NewsKIST develops multifunctional peptide that fights viruses and promotes wound healing
Researchers announced that they have developed a therapeutic substance with both antiviral and tissue regenerative properties, based on a peptide derived from natural sources.